Medtronic acquired rights and intellectual property related to Nanovis’ Sites Medical’s OsteoSync titanium pads, according to a Feb. 12 news release.
Medtronic will use the assets to develop PEEK interbody fusion devices. The FDA-designated bone-growth nanotechnology uses osseointegration to enhance implant fixation.
“Combining our market-leading nano surface technology with Medtronic’s market-leading PEEK implant designs will give a growing number of surgeons access to best-in-class devices to treat patients,” Brian More, Nanovis’ CEO, said in the release.
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will…
Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its…
Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus…